TITLE

High Prevalence of Thrombophilic Genotypes in Patients With Acute Mesenteric Vein Thrombosis

AUTHOR(S)
Amitrano, Lucio; Brancaccio, Vincenzo; Guardascione, Maria Anna; Margaglione, Maurizio; Iannaccone, Luigi; D'Andrea, Giovanna; Ames, Paul R. J.; Marmo, Riccardo; Mosca, Sandro; Balzano, Antonio
PUB. DATE
January 2001
SOURCE
American Journal of Gastroenterology;Jan2001, Vol. 96 Issue 1, p146
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
OBJECTIVES: Mesenteric vein thrombosis is a rare but severe abdominal emergency, often requiring intestinal resection. New genetic prothrombotic defects such as factor V Leiden, the prothrombin transition G20210A, and the methylenetetrahydrofolate reductase TT677 genotype have been described in association with venous thrombosis. Our goal was to assess prevalence and clinical significance of genetic thrombophilia in mesenteric vein thrombosis. METHODS: Twelve patients with acute mesenteric vein thrombosis were compared with 431 healthy people from the same geographical area. The factor V Leiden, the prothrombin transition G20210A, and the methylenetetrahydrofolate reductase TT677 genotype were identified by polymerase chain reaction and restriction analysis. RESULTS: A thrombophilic genotype was present in 9 patients (75%): the methylenetetrahydrofolate reductase TT677 genotype was present in 6 (50%), the factor V Leiden in 3 (25%), and the prothrombin transition G20210A in 3 (25%). Combined mutations were present in 4 (33%) patients. CONCLUSIONS: The factor V Leiden, the prothrombin transition G20210A, and the methylenetetrahydrofolate reductase TT677 genotype are important predisposing factors in the pathogenesis of mesenteric vein thrombosis. Their identification bears strong clinical implications for management of patients with mesenteric vein thrombosis.
ACCESSION #
17635418

 

Related Articles

  • Combined Factor V Leiden (R506Q) and prothrombin G20210A genotyping in young patients presenting with deep venous thrombosis. Mansilha, A.; Araújo, F.; Severo, M.; Sampaio, S. M.; Toledo, T.; Albuquerque, R. // Phlebology;2006, Vol. 21 Issue 1, p24 

    Objective: To evaluate the association between the Factor V Leiden (FV R506Q) and prothrombin gene (FII G20210A) mutations and deep venous thrombosis (DVT) in young people. Methods: Blood samples were drawn from 199 subjects: 100 healthy controls and 99 unselected patients, with an objectively...

  • Prothrombin C20209T mutation in deep vein thrombosis: a case report. Mariela Muñoz; Cristian Vilos; Mario Cantín // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 7, p11225 

    Thrombophilias is a recognized risk factor for thrombotic events. The prothrombin variant G20210A gene mutation has been commonly examined using polymerase chain reaction (PCR). Currently, in many clinical laboratories, performing the PCR in real-time technique, which, in addition to identifying...

  • Evaluation of the interactions of common genetic mutations in stroke subtypes. Szolnoki, Zoltán; Somogyvári, Ferenc; Kondacs, András; Szabó, Mihály; Fodor, Lajos // Journal of Neurology;Oct2002, Vol. 249 Issue 10, p1391 

    Objective: Ischemic stroke is a frequent heterogeneous multifactorial disease that is affected by several genetic mutations and environmental factors. We hypothesised the clinical importance of the co-occurrence of common, unfavorable genetic mutations in the development of different stroke...

  • Prevalence of thrombophilic gene polymorphisms in an Azari population of Iran. Bargahi, Nasrin; Farajzadeh, Malak; Poursadegh-Zonouzi, Ahmad; Farajzadeh, Davoud // Hematology Reports;2014, Vol. 6 Issue 2, p16 

    There is several evidence suggests that thrombophilic gene polymorphisms may influence susceptibility to thromboembolic events. The prevalence of these polymorphisms is different in various races and ethnics. Accordingly, we studied the prevalence of Factor V (G1691A and A4070G), prothrombin...

  • A mathematical model of in vivo methotrexate accumulation in acute lymphoblastic leukemia. Panetta, John; Yanishevski, Yuri; Pui, Ching-Hon; Sandlund, John T.; Rubnitz, Jeffrey; Rivera, Gaston K.; Ribeiro, Raul; Evans, William E.; Relling, Mary V. // Cancer Chemotherapy & Pharmacology;Nov2002, Vol. 50 Issue 5, p419 

    Methotrexate (MTX) is one of the most widely used drugs for the treatment of childhood acute lymphoblastic leukemia (ALL). Interindividual differences in lymphoblast accumulation of MTX and its active metabolites, methotrexate polyglutamates (MTXPG), may contribute to the effectiveness of...

  • The effect of malignant effusions on methotrexate disposition. Li, Jing; Gwilt, Peter // Cancer Chemotherapy & Pharmacology;Nov2002, Vol. 50 Issue 5, p373 

    Purpose. The purpose of this study was to evaluate the effect of malignant effusions on the pharmacokinetics of methotrexate (MTX). Methods. Simulated drug concentrations in blood, tissues and effusion fluid spaces were generated using a previously published physiologically based pharmacokinetic...

  • Hyperhomocysteinemia and of Methylenetetrahydrofolate Reductase (C677T) Genetic Polymorphism in Patients with Deep Vein Thrombosis. Brezovska-Kavrakova, Julijana; Krstevska, Marija; Bosilkova, Gordana; Alabakovska, Sonja; Panov, Saso; Orovchanec, Nikola // Materia Socio Medica;Sep2013, Vol. 25 Issue 3, p170 

    Aim: To determine the concentration of total plasma homocysteine (tHcy) as well as different genotypes of methylenetetrahydrofolate reductase MTHFR (C677T) in healthy subjects and patients with deep vein thrombosis (DVT). Material and methods: The investigation comprised a total of 160 subjects...

  • JAK2V617F Mutation in Patients with Portal Vein Thrombosis. Yusuf Bayraktar; Ozgur Harmanci; Yahya Büyükasik; Ali Shorbagi; Aysegul Sungur; Cemaliye Boylu; Aytemiz Gürgey; Ferhun Balkanci // Digestive Diseases & Sciences;Oct2008, Vol. 53 Issue 10, p2778 

    Abstract  In a retrospective cohort, we investigated the presence of the JAK2V617F mutation in chronic non-cirrhotic portal vein thrombosis (PVT) patients, irrespective of the presence or absence of myeloproliferative diseases (MPDs). We identified 25 patients in whom thrombophilia workup...

  • Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes. Jung, R; Petersen, K; Krüger, W; Wolf, M; Wagener, C; Zander, A; Neumaier, M // British Journal of Cancer;11/1/99, Vol. 81 Issue 5, p870 

    The reverse transcription polymerase chain reaction (RT-PCR) amplification of cytokeratin 20 (CK20) mRNA is considered a promising candidate method for the detection of circulating tumour cells in bone marrow and peripheral blood of cancer patients. In this study we have investigated the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics